Grigoris Chlouverakis
7PUBLICATIONS
68CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 13, 2026
Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6.Andreas Goette, Marc D Lemoine, Alexander Fierenz
|Jan 15, 2026
Defining obstruction in COPD: do fixed ratio and lower limit of normal criteria reflect different clinical characteristics? findings from a Greek cross-sectional study (EMENO).Μaria Gangadi, Natasa Kalpourtzi, Μagda Gavana
|Sep 02, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.Renate B Schnabel, Juan Benezet-Mazuecos, Nina Becher
|Aug 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.Hans Christoph Diener, Nina Becher, Susanne Sehner
|Apr 09, 2024
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.Gregory Y H Lip, Julius Nikorowitsch, Susanne Sehner
|Mar 31, 2023
Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO.Aliki I Venetsanopoulou, Natasa Kalpourtzi, Yannis Alamanos
Pageof 2
Frequent Collaborators
4 joint publications
Tobias Toennis
4 joint publications
A John Camm
4 joint publications
Antonia Zapf
4 joint publications
Paulus Kirchhof
4 joint publications
Emmanuel Simantirakis
4 joint publications
Ulrich Schotten
4 joint publications
Eloi Marijon
4 joint publications
Alexander Fierenz
3 joint publications
Μagda Gavana
3 joint publications
Yannis Alamanos
